DUBLIN--(BUSINESS WIRE)--The "Disposable Gloves Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031" report has been added...
Knowledge AI capabilities automate extraction of knowledge entities and graphs to empower real-time learning for intelligent virtual assistants and human...
New Fuel Cycle integration enables organizations to capture more context from their known community members SAN FRANCISCO--(BUSINESS WIRE)--#CX--UserTesting (NYSE: USER),...
RUTHERFORD, N.J., April 13, 2022 (GLOBE NEWSWIRE) -- Blue Foundry Bancorp (NASDAQ: BLFY) (the “Company”), the holding company for Blue...
Special closed-ended type private equity investment company INVL Technology, legal entity code 300893533, the registered address Gyneju str. 14 Vilnius,...
SES AI was founded on April 17th, 2012, originally as SolidEnergy Systems Over the past 10 years, SES AI has...
Early research suggests Pentarlandir is safe to use against COVID-19; Phase 3 trial evaluating effectiveness against both COVID-19 and influenza...
Clinical Knowledge Obtained Increases Probability of Success Compared to Drug Products Entering Phase I without Human Experience MELBOURNE, Australia--(BUSINESS WIRE)--Propanc...
QpiAI signed a Memorandum of Understanding (MoU) with Anglo-Finnish quantum control software company QuantrolOx QpiAI is opening an office in...
Today at the New York Auto Show, Subaru of America has announced that the 2023 Outback will be the first...
$6.1 Million investment for Pictor — led by Marko Bogoievski and K One W One Ltd. — to aid the...
ZURICH & LONDON & NOIDA, India--(BUSINESS WIRE)--#AI--HCL Technologies (HCL), a leading global technology company, has expanded its global partnership with...
Agreement shows strength of GPM’s successful growth strategy RICHMOND, Va., April 13, 2022 (GLOBE NEWSWIRE) -- GPM Investments, LLC, a...
DALLAS and WALL, N.J., April 13, 2022 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of workforce...
CAMBRIDGE, Mass. & BRISBANE, Australia--(BUSINESS WIRE)--Vaxxas, a clinical-stage biotechnology company commercializing a novel vaccination platform, is pleased to announce a...
